These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20039158)

  • 1. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doping control activities in Germany 1989-2006].
    Thevis M; Geyer H; Schänzer W
    Med Klin (Munich); 2008 May; 103(5):282-98. PubMed ID: 18484215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidoping in paralympic sport.
    Van de Vliet P
    Clin J Sport Med; 2012 Jan; 22(1):21-5. PubMed ID: 22222592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
    Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paralympic medicine.
    Webborn N; Van de Vliet P
    Lancet; 2012 Jul; 380(9836):65-71. PubMed ID: 22770458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping control analysis at the Rio 2016 Olympic and Paralympic Games.
    Pereira HMG; Sardela VF; Padilha MC; Mirotti L; Casilli A; de Oliveira FA; de Albuquerque Cavalcanti G; Rodrigues LML; de Araujo ALD; Levy RS; Teixeira PAC; de Oliveira FAG; Duarte ACG; Carneiro ACD; Evaristo JAM; Dos Santos GRC; da Costa GCV; de Lima Castro F; Nogueira FCS; Scalco FB; Pizzatti L; de Aquino Neto FR
    Drug Test Anal; 2017 Nov; 9(11-12):1658-1672. PubMed ID: 29078043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and accreditation of anti-doping laboratories for the Olympic Games.
    Botrè F; Wu M; Boghosian T
    Bioanalysis; 2012 Jul; 4(13):1623-31. PubMed ID: 22831478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use by athletes during the Athens 2004 Paralympic Games.
    Tsitsimpikou C; Jamurtas A; Fitch K; Papalexis P; Tsarouhas K
    Br J Sports Med; 2009 Dec; 43(13):1062-6. PubMed ID: 19850571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doping in sports].
    Jeschke J; Nekola J; Chlumský J
    Cas Lek Cesk; 1999 May; 138(10):291-7. PubMed ID: 10422337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doping and the Olympic games: the good, the bad, and the ugly.
    Lainscak M; Osredkar J
    Wien Klin Wochenschr; 2009; 121(1-2):13-4. PubMed ID: 19263009
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.